Delivery Order SPE2DB20D3101-SPE2DB25FRHS2
- Not listed
- The Defense Logistics Agency awarded a $17,105.21 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office as a leading pharmaceutical distributor serving federal...
- The Defense Logistics Agency (DLA) awarded a $7,010.69 delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30 count) with an ultimate completion date of September 4, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,726.30 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with a completion date of September 8, 2025. This non-competitive, firm fixed-price delivery order was issued on September 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,742.45. This competitively awarded, non-set-aside contract was executed on September 9, 2025, with an ultimate completion date of September 10, 2025, and reflects a firm fixed price arrangement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.13 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a routine pharmaceutical procurement executed through open competition without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,454.89 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of May 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $2,722.08 for Lidocaine 5% Patch 30-count units, with an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime...
- The Defense Logistics Agency awarded a $36,033.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of August 18, 2025. The contract, which was competitively awarded with no set-aside designation, will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for Lidocaine 5% Patch 30-count units with a ceiling value of $3,936.42. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,867.20 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical distributor will perform this delivery order from its corporate office location...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRHS2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,067.99 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30-count units) with an ultimate completion date of April 25, 2025. This firm fixed-price delivery order was awarded on April 24, 2025, without a set-aside designation, allowing the award to be made through open competition. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. The lidocaine patch delivery supports the DLA's broader mission to supply pain management and other critical pharmaceutical products to Department of Defense and other federal healthcare customers. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability across multiple therapeutic domains through its extensive federal contract portfolio with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.1k | 4/24/25 |